Virtual Medicinal Product (VMP) - Trastuzumab emtansine 160mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Trastuzumab emtansine 160mg powder for solution for infusion vials Start Date 10-02-2014 End Date
Abbreviated Name Abbreviated Name Trastuzumab emtansine 160mg inf vials Start Date 10-02-2014

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01FD03
BNF Start Date End Date
Current BNF 08010500 Start Date 04-04-2022 End Date
Previous BNF 08010500 Start Date 25-06-2014 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
23985511000001100 10-02-2014

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Trastuzumab emtansine Based on Ingredient Substance 160 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial